Company Filing History:
1 out of 832,680 Years Active: 2019
Title: Hongtao Xu: Innovator in Anticancer Drug Development
Introduction
Hongtao Xu is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer drugs. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Hongtao Xu holds a patent for a spirocyclic indolone polyethylene glycol carbonate compound. This invention includes a composition, preparation method, and its use as an anticancer drug due to its antitumor activity. The compound demonstrates excellent tumor inhibitory activity, water solubility, and low toxicity, making it suitable for intravenous injection.
Career Highlights
Throughout his career, Hongtao Xu has worked with various organizations, including Jiangsu Yayo Biotechnology Co., Ltd. His expertise in drug development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Hongtao Xu has collaborated with notable colleagues such as Jie Ma and Fei Xiao. Their combined efforts have contributed to advancements in drug formulation and development.
Conclusion
Hongtao Xu's innovative work in the field of anticancer drugs showcases his dedication to improving cancer treatment options. His contributions are vital to the ongoing fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.